Doctor profile · Federal record
Dr. PHILIP DUNN, D.O.
Rheumatology Physician (CMS: RHEUMATOLOGY) · ALLENTOWN, PA
- NPI 1962847772
- Accepts Medicare
- 13 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
798 HAUSMAN RD STE 100
ALLENTOWN, PA 181049116
(610) 776-5038 - Additional location
-
3615 Woodhaven Dr
Erie, PA 165061653
(814) 572-0550 - Mailing address
-
PO BOX 783311
PHILADELPHIA, PA 191783311
Credentials & registration
- NPI registered
- May 2013 — 13 yrs on file
- Profile last updated
- August 8, 2022
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Pennsylvania #OS017928
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1962847772. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
24,763
Distinct HCPCS
10
Medicare allowed
$296,128
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 18,800 | 13 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 4,920 | 56 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 347 | 235 | $122 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 149 | 97 | $95 | |
96372 |
Injection of drug or substance under skin or into muscle | 123 | 60 | $14 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 94 | 13 | $69 | |
J1030 |
Injection, methylprednisolone acetate, 40 mg | 52 | 29 | $8 | |
20610 |
Aspiration and/or injection of fluid from large joint | 51 | 35 | $75 | |
73130 |
X-ray of hand, minimum of 3 views | 40 | 21 | $26 | |
20610 |
Aspiration and/or injection of fluid from large joint | 35 | 23 | $52 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 1,056. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$17,078
Transactions
34
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 9 | $10,606.18 | |
| Amgen Inc. | 18 | $5,861.70 | |
| Alexion Pharmaceuticals, Inc. | 3 | $243.60 | |
| Novartis Pharmaceuticals Corporation | 2 | $186.79 | |
| UCB, Inc. | 1 | $124.74 | |
| Janssen Biotech, Inc. | 1 | $54.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,667
Patients
455
Total drug cost
$871,529
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 351 | 100 | $27,081 |
| Methotrexate (Methotrexate Sodium) | Brand | 324 | 78 | $11,040 |
| Prednisone | Generic | 271 | 87 | $2,697 |
| Allopurinol | Generic | 131 | 34 | $2,963 |
| Alendronate Sodium | Generic | 81 | 29 | $1,042 |
| Gabapentin | Generic | 75 | 27 | $1,913 |
| Tramadol Hcl | Generic | 72 | 13 | $768 |
| Humira(Cf) Pen (Adalimumab) | Brand | 70 | 0 | $552,865 |
| Celecoxib | Generic | 50 | 12 | $4,585 |
| Leflunomide | Generic | 46 | 13 | $8,070 |